Safety and pharmacokinetics of liposomal curcumin in healthy subjects:A randomized placebo-controlled double blind first-in human study.

被引：0

作者：

Storka, Angela ^{[1
]}

Wolzt, Michael ^{[1
]}

Vcelar, Brigitta ^{[2
]}

Bolger, Gordon ^{[3
]}

Majeed, Muhammed ^{[4
]}

Helson, Lawrence ^{[5
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Polymun Sci GmbH, Vienna, Austria

[3] Nucro Tech Inc, Scarborough, ON, Canada

[4] Sabinsa Inc, East Windsor, NJ USA

[5] Sign Path Pharma, Quakertown, PA USA

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-LB-165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB165

引用

页数：1

共 50 条

[31] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Li, Yi
Toyama, Kaoru
Nakatsu, Takafumi
Ishizuka, Hitoshi
Wu, Hailan
Cao, Guoying
Yu, Jicheng
Wang, Yu
Liu, Xiaofen
Guo, Beining
Wu, Jufang
Yu, Peimin
Hong, Zhen
Zhang, Jing
Wu, Xiaojie
ADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643
[32] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Yi Li
Kaoru Toyama
Takafumi Nakatsu
Hitoshi Ishizuka
Hailan Wu
Guoying Cao
Jicheng Yu
Yu Wang
Xiaofen Liu
Beining Guo
Jufang Wu
Peimin Yu
Zhen Hong
Jing Zhang
Xiaojie Wu
Advances in Therapy, 2023, 40 (4) : 1628 - 1643
[33] Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
Venkateshwarlu Kudiganti
Raveendra Ramamurthy Kodur
Sushma Raveendra Kodur
Manjunath Halemane
Dheeraj Kumar Deep
Lipids in Health and Disease, 15
[34] Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
Kudiganti, Venkateshwarlu
Kodur, Raveendra Ramamurthy
Kodur, Sushma Raveendra
Halemane, Manjunath
Deep, Dheeraj Kumar
LIPIDS IN HEALTH AND DISEASE, 2016, 15
[35] A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects
Yang, Haijing
Wang, Peipei
Li, Xin
Wei, Qiong
Yu, Jicheng
Wu, Xiaojie
Huang, Ying
Li, Ruowan
Du, Weijuan
Zeng, Shaoqing
Wu, Hailan
Wang, Shuhai
Zhang, Jing
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
[36] Safety, pharmacokinetics and biologic volunteers: Results of a placebo controlled randomized double-blind phase 1 study.
Serdar, CM
Heard, R
Prathikanti, R
Lau, D
Danilenko, D
Hunt, T
Lacey, D
BLOOD, 1997, 90 (10) : 761 - 761
[37] A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects
Xie, Panpan
Abildlund, Morten T.
Baekdal, Tine A.
He, Xuemei
Lyauk, Yassine K.
Patted, Usha Rani H.
Ning, Zu
Shi, Aixin
DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3068 - 3077
[38] Phase I, double-blind, placebo-controlled study in healthy male subjects to investigate the safety, tolerability, and pharmacokinetics of DA-8159
Padma-Nathan, H
Pacik, JS
Ahn, BO
Kang, KK
Bahng, MY
Kim, WB
JOURNAL OF UROLOGY, 2004, 171 (04): : 234 - 234
[39] Effects of acotiamide on esophageal motility in healthy subjects: a randomized, double-blind, placebo-controlled crossover study
Hoshino, Shintaro
Takenouchi, Nana
Hanada, Yuriko
Umezawa, Mariko
Sano, Hirohito
Kawami, Noriyuki
Hoshikawa, Yoshimasa
Kawagoe, Tetsuro
Nomura, Tsutomu
Hoshihara, Yoshio
Iwakiri, Katsuhiko
ESOPHAGUS, 2017, 14 (02) : 146 - 152
[40] Effects of acotiamide on esophageal motility in healthy subjects: a randomized, double-blind, placebo-controlled crossover study
Shintaro Hoshino
Nana Takenouchi
Yuriko Hanada
Mariko Umezawa
Hirohito Sano
Noriyuki Kawami
Yoshimasa Hoshikawa
Tetsuro Kawagoe
Tsutomu Nomura
Yoshio Hoshihara
Katsuhiko Iwakiri
Esophagus, 2017, 14 : 146 - 152

← 1 2 3 4 5 →